Učitavanje...
Relevance of genetic alterations in squamous and small cell lung cancer
The precision medicine revolution has led to the development and US FDA approval of multiple targeted therapies in non-squamous non-small cell lung cancers, including tyrosine kinase inhibitors targeting EGFR, ALK, and ROS1. However, the development of targeted therapies for squamous cell lung cance...
Spremljeno u:
| Izdano u: | Ann Transl Med |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
AME Publishing Company
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5635252/ https://ncbi.nlm.nih.gov/pubmed/29057233 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2017.06.72 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|